PCR Monocyte Activation Testing for Endotoxin and Non-Endotoxin Pyrogens

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current animal-based pyrogen tests, such as the Rabbit Pyrogen Test (RPT) and Limulus Amoebocyte Lysate (LAL), suffer from limitations including variability, low sensitivity, ethical concerns, and limited availability, making them inadequate for reliable detection of both endotoxin and non-endotoxin pyrogens in pharmaceutical products.

Innovation Solution

A monocyte activation test using the THP-1 cell line model that measures the expression of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, and TNFα) via PCR techniques, specifically quantitative real-time PCR (qPCR) or digital PCR (dPCR), to detect a wide range of pyrogens, including endotoxins and non-endotoxins, in pharmaceutical products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If animal-based tests (RPT, LAL) are used for pyrogen detection, then the testing process is established and routine, but the sensitivity and reliability are limited and variability is high

Engineering Contradiction:

Improvedetection reliabilityVSAvoiddetection sensitivity

Core Design Contradiction:

ReliabilityVSMeasurement precision

Solution Approach 1:

The patent replaces animal-based physiological response systems (RPT measuring temperature change in rabbits, LAL measuring coagulation in horseshoe crab lysate) with a molecular biological system based on monocyte activation and nucleic acid amplification (PCR). This substitution enables direct detection of pyrogen-induced cytokine gene expression at the molecular level, achieving detection limits in the picogram range for endotoxins and broader specificity for non-endotoxin pyrogens, thereby resolving the contradiction between reliability and measurement precision.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from physiological responses (temperature, coagulation) to molecular biomarkers (cytokine mRNA expression levels). By quantifying gene expression of pro-inflammatory cytokines (IL-1β, IL-6, TNFα, IL-8) using PCR techniques, the method achieves higher sensitivity and reliability in pyrogen detection while eliminating animal variability and subjectivity in interpretation.

Inventive Principle:

Principle #35Parameter changes

2Adaptability or versatility

If animal-based tests are used, then the testing capability is maintained, but ethical concerns arise and availability is limited

Engineering Contradiction:

Improvedetection capabilityVSAvoidavailability and ethical acceptability

Core Design Contradiction:

Adaptability or versatilityVSEase of operation

Solution Approach 1:

The patent substitutes animal-based testing systems with an in vitro human monocyte cell-based assay combined with molecular biology techniques. This replacement eliminates all ethical concerns associated with animal experimentation while maintaining and enhancing detection capability through direct measurement of human immune cell responses to pyrogens, thus resolving the contradiction between adaptability and ease of operation.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If traditional ELISA-based monocyte activation test is used, then the detection of cytokines is possible, but the sensitivity and speed are insufficient

Engineering Contradiction:

Improvedetection accuracyVSAvoiddetection speed

Core Design Contradiction:

ReliabilityVSProductivity

Solution Approach 1:

The patent replaces the ELISA-based protein detection system with a nucleic acid amplification system (PCR). By detecting cytokine mRNA expression through genetic amplification rather than protein quantification, the method achieves both higher sensitivity (detecting lower pyrogen concentrations) and faster results (real-time or digital PCR provides rapid quantification), thereby resolving the contradiction between reliability and productivity.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides high sensitivity and specificity for detecting pyrogens, overcoming the limitations of traditional tests by ensuring accurate and reliable detection across various pyrogen types, thus enhancing drug safety without ethical or availability concerns.

Implementation Method 1

The invention comprises the process from treating immune competent cells with the medicinal product to be tested, the extraction of nucleic acids and the detection of cytokines by PCR-techniques

Methodology Applied

Scientific EffectPolymerase chain reaction:

Implementation Method 2

The present invention will enable the detection of pyrogens in medicinal products reliably and fast by the employment of the techniques of the polymerase chain reaction (PCR), quantitative real-time PCR (qPCR) and digital PCR (dPCR)

Methodology Applied

Scientific EffectQuantitative real-time PCR:

Implementation Method 3

Methodology Applied

Scientific EffectDigital PCR:

Data Source

PatentUS20250320553A1Method and detection kit for the detection of pyrogens in biological samples

Publication Date: 2025.10.16 MINERVA BIOLABS GMBH

AI summary

In a method and a detection kit for the detection of pyrogens in a biological sample, immune cells are brought into contact with the sample, which may contain pyrogens, whereby the expression of immunomodulatory mediators takes place, wherein after lysis of the immune cells the nucleic acids of the immune cells are extracted and the expression of immunomodulatory mediators is detected by means of PCR. At least one of three different cytokines/chemokines are detected in parallel. The method and the detection kit can be used for the detection of endotoxin and non-endotoxin pyrogenic contaminations in a medicinal sample.